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ABSTRACT
Infectious diseases are one of the major causes of economic losses 
in poultry industries. In many instances, there are no specific signs 
that are associated with a particular disease. Besides clinical signs 
and findings from post mortem examinations, diagnostic tools based 
on serological and molecular detections are used to confirm the 
causative agents. However, the identification of causative agents 
and the detection of specific antibody responses in relation to a 
clinical problem are complicated due to the concurrent infections 
and improper use of vaccines. Currently, the poultry industry is 
threatened by more virulent viruses of endemic diseases or by exotic 
and emerging diseases that can cause major economic losses to this 
sector.  The emergence and re-emergence of avian influenza virus 
(AIV),  particularly the highly pathogenic avian influenza (HPAI) 
H5N1, the presence of endemic low pathogenic avian influenza 
(LPAI) H9N2 in poultry flock and recently the detection of the 
novel H7H9 and H10N8 in certain regions in China  posed threats 
to the poultry industry and public health sector. Infection with HPAI 
such as H5N1 is easy to diagnose. However, the real challenge is to 
confront H7N9, H9N2, H10N8 and other LPAI which act in concert 
with other factors such as management, environment, nutrition 
and concurrent infections which possess a continuous threat to 
the entire poultry production system.  The repeated outbreaks of 
diseases caused by variant strains of infectious bronchitis virus 
(IBV), velogenic Newcastle disease viruses (NDV) and more 
virulent viruses of infectious bursal disease virus (IBDV), infectious 
laryngotracheitis virus (ILTV) and Marek’s disease virus (MDV) 
in well managed poultry flocks have prompted the need to evaluate 
the underlying factors contributing to the failure of vaccinations 
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to provide protection against clinical infections and transmission 
of disease.
 In the field, vaccination failure is a complex event involving 
various factors associated with vaccine strains and vaccination 
program, the virulence of field pathogens and the host immune 
competence. In many situations, immunosuppressive agents, 
primarily the MDV, IBDV and chicken anemia virus play an 
important role in increasing the susceptibility of chickens to 
opportunistic infections and/or suppressing effective vaccine 
induced responses. Vaccination is the most cost-effective method 
available in preventing economic losses and increasing the lifespan 
of animals. Undoubtedly, diagnostic tools, vaccines and vaccination 
equipment have improved over the years through the use of 
innovative technology.  However, vaccine is not evolution-proof 
and it may enhance virus evolution especially in the absence of 
sterilizing immunity allowing wild type viruses to be transmitted 
through vaccinated chickens.
 Despite advancements in genetic engineered tools, conventional 
laboratory diagnosis using serological tests and conventional 
vaccines are used extensively in health and disease management 
of poultry. Nearly all poultry vaccines are conventional vaccines 
which consist of live-attenuated and killed vaccines that have 
generally worked well. However, avian pathogens continue to 
change and develop ways to evade the immunity induced by the 
current vaccines.  In addition, as the poultry industry become more 
intensive, accurate, economical and practical laboratory diagnostic 
tools are important for the effective control of disease outbreaks. 
The advancements in the use of molecular detection method 
using real-time PCR approach, highly automated instruments for 
antibody detection and development of rapid on site assays for 
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virus antigen detection may have significant impact in the field of 
disease prevention and control. In the area of vaccinology, most of 
the advances in the development of recombinant vaccines against 
poultry diseases are based on the development of recombinant viral 
vectored, DNA plasmid and reverse genetic vaccines. However, it 
is anticipated that more recombinant based vaccines will be used in 
the field in the near future. In addition, the advancement on “omic” 
technology are paving novel approaches for the development of 
new generation adjuvants and vaccines as well as breeding for 
disease resistance based on our improving knowledge of the chicken 
immunogenomic response to disease. However, the development 
and delivery of new or improved poultry diagnostics, vaccines and 
pharmaceutical which fulfill the industry, regulatory and public 
acceptance is a challenging process.   
 Although the majority of poultry viruses are pathogenic to 
chickens, some of them especially NDV has the potential to act as 
a live saver in humans due to its unique properties as viral vectored 
vaccine against other infectious diseases and selective oncolytic 
properties on human cancer cells.  The continuous encouraging 
results of NDV oncolytic virotherapy in human clinical trials will 
facilitate the approval of NDV as an ancillary therapy of human 
cancer in the near future. Innovative research on the use of NDV 
as human vaccines and therapeutics should be explored via multi-
disciplinary approach by various expert groups.
 In conclusion, as the poultry industry is expanding and the 
globalization of poultry and poultry by products, much is needed 
to improve the control and prevention of diseases. The emerging 
and emerging of diseases especially transboundary diseases can 
impact socioeconomic of a country and global food security. The 
strengthening our scientific and technical capacity, especially 
❚❘❘ 4
Poultry Viruses:  From Threat to Therapy
through innovative technology and strategy, will help to meet the 
current challenges and ever changing needs of the nation and the 
world.   
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INTRODUCTION
Livestock production is growing rapidly as a result of the increasing 
demand for animal products. FAO projections suggest that global 
meat production and consumption will rise from 233 million 
tonnes (2000) to 300 million tonnes (2020), and milk from 568 to 
700 million tonnes over the same period. Egg production will also 
increase by 30 percent. This forecast shows a massive increase in 
animal protein demand, needed to satisfy the growth in the human 
population. Asia is experiencing the world’s highest growth rates 
in production and consumption of livestock products (meat, milk 
and eggs). The Malaysian livestock industry is an important and 
integral component of the agricultural sector, providing gainful 
employment and producing useful animal protein food for the 
population. Poultry and pig farming represent by far the major 
proportion of the livestock industry in terms of output value. 
Malaysia is self-sufficient in poultry, pork and eggs, but imports 
about 80% of its beef requirement (http://www.mida.gov.my/env3/
index.php?page=food-industries). 
 Although our poultry industry is self-sufficient, the industry is 
facing constant threats and challenges. Productivity is influenced 
primarily by the soaring prices of feed whilst infectious diseases 
caused by viruses and bacteria have significant economic impact to 
the entire value chain of poultry production. Even though viruses 
are smaller than bacteria, they are more difficult to control and are 
classified into different families based on their genomic nature 
(Figure 1). Viral diseases such as avian influenza (AI) and Newcastle 
disease (ND) which are also known as transboundary diseases are 
highly contagious or transmissible and have the potential for very 
rapid spread, irrespective of national borders, causing serious socio-
economic and possibly public health consequences (Omar, 2013). 
In many cases, outbreaks of the diseases have been widespread 
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and often transnational and have severely challenged the ability of 
governments to control them.  In the case of avian influenza virus, 
the impact of the virus to the public health sector cannot be taken 
lightly since the four pandemics that had occurred in the last 100 
years were associated influenza virus of avian species crossing 
to humans.  In addition, some viral infectious diseases such as 
infectious bursal disease (IBD) (Gumboro disease) and chicken 
infectious anemia (CIA) and Marek’s disease (MD) which may 
induce immunosuppression are able to cause significant impact to 
the health status of the birds, preventing  them from responding 
optimally to the vaccinations against different diseases. 
 Viruses, particularly the RNA viruses can evolve rapidly due to 
their short generation time and higher mutation rate compared to the 
DNA viruses. Some viruses such as AI virus can shuffle (re-assort) 
their genes with other influenza viruses when two or more strains 
are  infecting the same cell whilst, most RNA viruses also evolve 
by recombination process by exchange of genetic materials with 
other related viruses. This has been demonstrated in existence of 
more than 100 different strains of avian infectious bronchitis virus 
(IBV), a virus classified under the family coronavirus (Zarirah et 
al., 2009). Likewise, studies have shown that the emergence of 
new coronavirus affecting humans such as severe acute respiratory 
syndrome coronavirus (SARS-CoV) and more recently in 2012, 
Middle East Respiratory Syndrome Coronavirus (MERS-CoV) 
(Hofer, 2013). Meanwhile, other viruses including DNA virus 
change slower via mutation process in their genes which gradually 
accumulate over time. In the presence of selection pressure such as 
anti-viral drugs, vaccines and/or new susceptible hosts, the mutation 
rate of viruses may increase. These different processes can occur 
simultaneously producing a new strain or subtype of viruses that 
are far more superior that the predecessor in many ways i.e. highly 
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virulent, resist antiviral drug, vaccine-escape strains and increase 
in host range susceptibility (Lee et al., 2012).
 Our research group is working through its researches and 
with industries to address the various challenges from several 
different poultry viral diseases namely the avian influenza virus 
(Orthomyxovirus), Newcastle disease virus (Paramyxovirus), 
infectious bronchitis virus (Coronavirus), infectious bursal 
disease virus (Birnavirus), chicken infectious anemia virus 
(Circovirus), fowl adenovirus (Adenovirus) and Marek’s disease 
virus (Herpesvirus) (Figure 1). Effective disease control requires 
rapid and accurate detection tools coupled with effective vaccines 
to control the outbreak. Hence, our group has been interested to 
develop diagnostics, vaccines and other therapeutics against several 
economically important poultry diseases. Currently, most of the 
laboratory diagnosis of avian disease is via conventional method 
including serological based assays (Omar, 2005).  Nevertheless, 
laboratory diagnosis based on molecular approach using PCR, 
real-time PCR and sequencing is getting more and more important 
(Figure 2). In the case of vaccines, the majority of the poultry 
vaccines are conventional live attenuated and killed vaccines that 
are formulated against several important bacterial and viral diseases. 
Numerous studies have been carried out on the development of 
new generation of vaccines using genetic engineered (reverse 
vaccinology) technology (Figure 5 and 6). Emphasis is also given to 
develop new adjuvants which are able to enhance vaccine induced 
immunity.  However, only a handful of some of the developed new 
vaccines and adjuvants show huge potential for application in a 
commercial setting. 
 In order to increase the value proposition of our research 
and innovation, early buy in and active engagements are being 
carried out with industries in an effort to bring new diagnostics 
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and vaccines for animals since prudent measures for control and 
surveillance of poultry infectious diseases are needed to safeguard 
both animal and human safety and welfare. This is in line with the 
Department of Veterinary Service (DVS) decision in looking into 
ways of producing more poultry vaccines, in mitigating Malaysia’s 
heavy reliance on imported vaccines (http://www.thepoultrysite.
com/poultrynews/22972/malaysia-looking-to-produce-poultry-
vaccines). Currently, our group has successfully commercialized 
4 poultry vaccines, a few more vaccines and diagnostic kits are 
scheduled to be commercialized by next year through relevant 
industry partners.  
 In an effort to explore the use of poultry viruses in comparative 
medicine and biomedical sciences, our group is also working closely 
with various expert groups in exploring the possibilities of using 
poultry viruses namely NDV as  oncolytic virotherapy against 
human cancer. The use of oncolytic virus has enable researchers 
to develop strategies for both selective destruction of cancer cells 
and activation of immune responses against residual cancer cells 
(Nakajima et al., 2013). Numerous studies both in vitro and in 
vivo animal models have demonstrated the potentials of NDV as 
a safe and effective therapy against human cancer. Additionally, 
the potentials of NDV as an oncolytic therapy is currently been 
tested at phase II/III clinical trials in several countries (Lam et al., 
2011). However, more work still need to be conducted especially 
to address the fundamental understanding of NDV selective lysis of 
cancer cells as well as the safety and ethical issues for public and 
regulatory acceptance of NDV as one approach that is available for 
treatment of cancers. 
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Figure 1 Classification of viruses. Viruses are classified based on the 
presence of lipid envelope and their nucleic acid either DNA or RNA 
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WHY VIRAL DISEASES ARE DIFFICULT TO 
CONTROL? 
Poultry diseases caused by pathogenic bacteria and viruses are 
causing constant threats to poultry industry not only in large 
commercial flocks, but also in backyard chickens throughout the 
world. However, viral diseases are the most common causes of 
losses compared to bacteria diseases due to several main reasons 
as follows;  
•	 Viral diseases can reduce flock performance without showing 
obvious clinical diseases, hence, being subclinical they can 
spread easily.  
•	 Viruses can act as the primary agent causing damage to primary 
tissue for other infectious agents to infect and cause more 
damaging diseases, hence, causing a complex disease syndrome 
that is difficult to detect and manage.  
•	 Effects of viral diseases are more damaging since they usually 
can affect more than one body systems. Furthermore, some 
viral diseases are able to cause immunosuppression due to 
their ability to destroy immune cells such as lymphocytes and/
or macrophages.
•	 The only means to control viral diseases is through vaccination 
which requires healthy host immune systems. Besides, 
antibiotic works only against bacterial infection. 
•	 Many farms are practising multi-age rearing, viruses can build 
up on farms and this can put a huge toll on vaccine to work 
effectively.
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•	 Vaccine is not evolution-proof.  The use of vaccine may enhance 
virus evolution especially in the absence of sterilizing immunity 
allowing wild type viruses to be transmitted through vaccinated 
chickens.  
•	 Many viruses are able to resist decontamination procedure 
hence, they persist in farm environment and infected chickens 
act as carriers intermittently shed the virus. More importantly, 
many of the routine diagnostic tests are unable to detect the 
virus shedding.
 If you ask poultry farmers in many countries including 
Malaysia as to which poultry viral diseases that they are really 
concerned of, their most likely answers would be avian influenza 
(AI),  Newcastle disease (ND), infectious bronchitis (IB), infectious 
bursal disease (IBD @ Gumboro), egg drop syndrome (EDS) and 
chicken infectious anemia CIA). Other viral diseases of concerned 
especially in layers and breeder are diseases associated with viruses 
that are able to cause tumor (oncogenic viruses) such as Marek’s 
disease and avian leucosis. However, in the field situation, the 
scenario may be different. Viral challenges can be the triggers by a 
whole range of problems including non-infectious disorders but can 
have an even more devastating effect on overall flock performance, 
production and profits. These viral diseases have been considered 
to cause serious threat to the poultry industry either by causing 
direct economic losses due to high morbidity and mortality or 
indirect losses due to immunosuppression and/or restriction to 
export due to international trading policies.  The viruses associated 
with these diseases in Malaysia has been isolated and characterized 
by several researchers. Most of the work focused on isolation and 
characterization of the viruses such as  NDV (Salih et al., 2000b; 
Yusoff and Tan, 2001; Tan et al., 2004b; 2010; Berhanu et al., 
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2010; Tan et al., 2010), variant IBV (Zarirah et al., 2009; Balkis 
et al., 2005), very virulent IBDV (Chong et al., 2001; Hoque et 
al., 2001;  2002; Phong et al., 2002b; 2003; Kong et al., 2004a, b; 
Tan et al., 2004a; Nurulfiza et al., 2006; 2011), CAV (Chowdhury 
et al., 2002; 2003; Hasmah et al., 2004; Hailemariam  et al., 
2008), ALV-J (Thapa et al., 2004), adenovirus (Alemnesh  et al., 
2012; Juliana et al., 2012) and several different subtypes of AIV 
(Balasubramaniam et al., 2011; 2012; 2013; Chaharaein et al., 
2006; 2009) for the development of diagnostics and vaccines. The 
isolation and characterization of some of these viruses in other 
countries using expertise from UPM researchers have also been 
carried out in studies by Bahmaninejad et al. (2008), Hosseini et 
al. (2004), Kianizadeh et al. (2002) and Sharma et al. (2005) and 
Kammon et al. (2013). 
 Although various factors such as environment, nutrition 
and management play an important role in the full expression 
of diseases, the most significant underlying factor is usually the 
infectious agent, how different and virulent is the infecting viruses. 
Since most RNA viruses such as AIV, IBV, NDV undergo various 
processes leading to emergence of new genotypes or strains of 
viruses with different phenotypic characteristic. For instance, the 
emergence of HPAI H5N1 strain that is able to cause fatal infection 
in migratory birds and causing efficient transmission of the virus 
in experimental infection in mouse model as well as causing fatal 
infection in larger mammals such as tigers and cats (reviewed by To 
et al., 2012). Low pathogenic AIV such as H9N2 has been known for 
more than 20 years to cause mild infection in human and now there 
are evidences indicating the virus is drifting rapidly and becoming 
more virulent in chickens and humans (Shanmuganatham et al., 
2013). More recently, we faced another concern of AIV jumping 
host causing infection in human, the emergence of novel low 
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pathogenic AIV H7N9  and H10N8 strains that cause mild infections 
in chickens but is able to infect and cause fatal human infections 
(Gao et al., 2013; Garcia-Sastre and Schmolke, 2014). Currently, 
H7N9 is endemic in certain part of China, and Malaysia reported 
the first H7N9 in human from a tourist from  Guangdong Province, 
China who visited Sabah early this year (http://www.cidrap.umn.
edu/news-perspective/2014/02/malaysia-reports-first-h7n9-case-
outside-china). The current H7N9 infection in China is spreading 
to the neighbouring countries where the virus has been detected in 
live poultry markets and humans in northern part of Vietnam. The 
detection of new strain of H10N8 early this year in eastern China 
resemble of H7N9 virus, where the virus cause mild infection in 
poultry but fatal human infection. So far, there is no evidence of 
efficient human to human transmission in the spread of H7N9 and 
H10N8  viruses.  However, recent study confirms that the HPAI 
H5N1, and the H7N9 and H10N8 viruses have internal genes from 
H9N2, indicating that the on-going circulating of H9N2 virus may 
play important role in the emergence of new strains of AIV with 
significant threat to human (Garcia-Sastre and Schmolke, 2014). 
 Even though LPAI viruses such as H5N2 and H9N2 are less 
virulent in chickens, they are able to trigger other infections 
primarily bacteria and mycoplasmas to take place and subsequently 
causing a more serious diseases. Meanwhile, there are a number 
of avian viruses that are able to exert direct or indirect insult to the 
chicken immune system causing immunosuppression (reviewed 
by Omar, 2005). This can pose a significant impact to the health 
status of the birds, preventing  the bird from responding optimally 
to the vaccinations against different diseases. In the case of NDV, 
although the virus can be divided into at least 10 different genotypes, 
most of the poultry farms in this region including Malaysia are 
facing constant threats from the outbreaks of virulent genotype VII 
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NDV despite vaccination effort (reviewed by Miller et al., 2010). 
In fact, outbreaks of genotype VII NDV have been reported in 
various countries in Far East and South America. Furthermore, the 
emergence of variant strains of IBV, ie Qx-like and very virulent 
IBDV that are able to break immunity induced by vaccination with 
classical strains of the respective viruses are commonly reported 
in poultry flocks (reviewed by Jackwood, 2012; Ingrao et al., 
2013). DNA viruses although to the less extend compared to RNA 
viruses also undergo genetic alteration especially in the presence 
of immune selection. Studies have also showed the continuous 
emergence of very virulent MDV that are able to break vaccine 
induce immunity (reviewed by Nair, 2005), whilst in the case of 
infectious laryngotracheitis (ILT), the emergence of pathogenic 
ILT virus (ILTV) strains from recombination of different live ILTV 
vaccine strains (Lee et al., 2012).  All in all, viruses have developed 
various strategies to evade and invade the immune functions and co-
exist within its host and induce an infectious disease in a host with 
depressed resistance.
CURRENT DIAGNOSTICS AND VACCINES FOR 
POULTRY
Laboratory Diagnostic Assays 
Generally diagnostic assays for detecting infectious agents can be 
divided as serological or molecular based (Figure 2) where most 
viral infections can be diagnosed by the detection of (part of) 
the virus itself or the specific antibody responses (Table 1). The 
most commonly used laboratory diagnosis method is the virus 
isolation (VI) via embryonated chickens eggs or cell culture which 
require serology tests for confirmation. Serological tests that are 
commonly used are enzyme-linked immunosorbent assays (ELISA), 
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immunofluorescence assay (IFA), immunoperoxidase assay (IPA), 
agar gel diffusion precipitin test (AGPT) and virus neutralization 
test (VNT).  In some viral agent such as NDV, AIV and IBV assays 
such as hemagglutination (HA) and hemagglutination inhibition 
(HI) are commonly used to diagnose a clinical problem (reviewed 
by Omar, 2005). 
 Among the available serology tests, the ELISA procedure is 
the most commonly used for the evaluation of antibodies in poultry 
flocks following immunization programs (Phong et al., 2002a; 
Wong et al., 2009; Omar, 2005). ELISA can also be used to detect 
infection by statistically analyzing the kinetics of the antibody 
titer from paired serum sets. In addition, the ELISA has been 
showed to correlate well with other serological test namely HI in 
the detection of NDV and IBV. Our group has developed ELISA 
against NDV and IBDV by using recombinant viral protein such 
as nucleoprotein (NP) and VP2 protein, respectively, expressed 
in E. coli (Rabu et al., 2002; Hoessini et al., 2007). Recently, we 
have also studied the potential of NS2 protein expressed in yeast 
expression system as diagnostic assay to detect AIV (Abubakar et 
al., 2011).  The performances of these assays are currently under 
evaluation. One of the major requirements in laboratory diagnosis 
of a disease is the speed and accuracy of the test. However, the 
majority of on-site test kits that are currently available are very rapid 
but lack sensitivity (Figure 3). Nevertheless, the advancements in 
monoclonal antibody technology in detecting different subtypes 
and strains of AIV, IBDV and IBV, respectively (reviewed by Omar, 
2005) probably may address some of these limitation. However, this 
assay is limited by the monoclonal antibodies used and additional 
monoclonal antibodies will be needed as new antigenic strains are 
identified. Virus neutralization test (VNT) has been extensively used 
for serological testing and is considered as gold standard assay for 
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variety of diseases. However, this method is more tedious and not 
suitable to be used as a routine procedure.  
Figure 2  Different technologies in laboratory diagnosis. 
Conventional approach such as virus isolation and culture, serology 
based on ELISA and molecular based such as PCR, NASBA and 
sequencing.  
 Rapid progress has been made in the development of 
diagnostic method using molecular techniques (Figure 2 and 4). 
Polymerase chain reaction (PCR) based detection techniques have 
been developed to detect various poultry viruses based on the 
amplification of specific genes. The use of PCR technology followed 
by restriction fragment length polymorphism (RFLP) analysis or 
development of specific probes in a hybridization based detection 
technique has been shown to detect specific strains of a viral agent. 
However, their applications in diagnosing large number of clinical 
samples are problematic due to the insensitivity of the agarose gel 
detection method and the use of hazardous reagents such as ethidium 
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bromide and radioactive materials.  Compared to the conventional 
PCR, nested or multiplex PCR, colorimetric PCR, real-time PCR 
have several advantages as laboratory diagnostic tools (Tan et al., 
2004b; 2009; Phong et al., 2003; Chaharaein et al., 2006; 2009; 
Hairul et al., 2008). However, besides conventional PCR, only 
nested, multiplex and real-time PCR are currently being used in 
the detection of poultry viruses. 
Figure 3 Comparison between field (on-site) and laboratory based tests
Figure 4 Comparison between gene function/expression and gene 
discovery
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Avian Vaccinology
Poultry industry is growing rapidly in size worldwide. Under the 
intensive management condition, prevention of infection through 
effective vaccination is vital to minimize losses due to infectious 
diseases. Vaccines are available for variety of poultry diseases. 
Active and passive immunizations are practiced to control diseases 
in poultry.  However, numerous factors can modulate the ability of 
the host to produce immunity. Vaccination should be carried out 
at a time when the host is immunologically competent. In most 
cases, this means that for an optimal response, vaccine should not 
be administrated until at least third week of age. In addition, both 
humoral and cell-mediated immunity (CMI) are age-dependent. 
Unfortunately, exposure to many infectious agents can occur 
before the optimum vaccination time. Thus, it is necessary to 
compromise this principle. In this case, depending on the type 
of the vaccines, immune responses may be obtained, but it is of 
a lower level and often requires subsequent vaccination to boost 
immunity and protection levels. Exceptions to this principle, for 
instance is MD vaccine which causes persistent life-long infections 
and thus provide a continuous antigenic stimulation (reviewed 
by Omar, 2006a). The use of veterinary vaccines has somewhat 
different requirements than the use of human vaccines. One of the 
limitations of veterinary vaccines is the cost especially poultry 
vaccines when they are required on a large scale of tens of billions 
of dose annually. Hence, most poultry vaccines consist of viruses 
of the same genus but different strains and/or totally of different 
families of viruses. The bivalent and trivalent MDV vaccines 
which constitute of the serotype 1, 2 and/or 3 MDV and polyvalent 
vaccines constitute of NDV, IBV and reovirus are commonly used 
in poultry industry (reviewed by Omar, 2006b). In addition, most 
of the vaccines are administered through mass vaccination methods 
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such as through drinking water and spraying. The technology of 
administrating vaccines in ovo has also been developed for some 
viruses namely MDV, NDV, IBDV and fowlpox virus. Another 
interesting development in poultry vaccines is the development of 
strong IBDV immunity in chicks with high maternal antibody after 
administration of IBDV and IBDV-specific antibodies, whereby 
this type of IBD vaccine is commercially available. 
Avian Viral Immunology 
Chicken immune system is very similar to mammals and shares 
common features in the classification of innate and acquired 
immunity and the presence of different population of cells such 
as B cells, T cells, NK cells, macrophages and inflammatory cells. 
The mechanisms associated with vaccine induced immunities 
against different pathogens have been reviewed by several groups 
(reviewed by Omar, 2005).  Simply providing immune responses 
following vaccination may not be enough. The immune responses 
must be of the right type and against the right antigens. Neutralizing 
antibodies directed against conformationally-dependent epitopes of 
the fusion (F) and haemagglutinin-neuramidase (HN) of NDV, VP2 
of IBDV, spike (S1) of IBV, haemagglutinin (HA)  of AIV,  VP1 and 
VP2 of CAV induced protection against lethal challenge with the 
respective viruses (reviewed by Omar, 2005).  Meanwhile, it has 
been showed that CMI play important role in inducing protection 
against infections with ILT, MDV and IBV but not against NDV 
and  IBDV (Omar and Schat, 1998; Omar, 2005). Protection 
against systemic infections of NDV and IBDV might be induced 
by injection of killed virus vaccine. However, this attempt might be 
useless in protecting against respiratory or digestive tract infections 
as local or mucosal immunity might be needed. However, studies 
have also indicated that oil adjuvant killed vaccines gave markedly 
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superior responses obtained following a primary inoculation with 
a live vaccine. The antibody responses following this procedure 
are exceptionally high, long lasting and are readily transferred to 
day-old chicks. 
 Besides immune cells, various immune mediators such as 
cytokine, interferon, interleukin, chemokine, nitric oxide and 
many others also play important roles in providing a full spectrum 
of protection against viral infections (reviewed by Kaiser et al., 
2010).  In addition, mediators from Th1 cells and macrophages such 
as interferon-gamma (IFN-g), tumour necrosis factors and  nitric 
oxide are important in certain virus infections especially that are 
highly cell-associated such as Marek’s disease virus (reviewed by 
Schat, 2004).  
Figure 5  Different types of conventional and recombinant viral 
vaccine.  Live and inactivated vaccines compared to recombinant 
vaccines based on viral vector, bacterial vector, peptide, subunit and 
DNA plasmid. 
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Figure 6  Comparison between reverse vaccinology over conventional 
vaccine development.   Fast access to virtually every single antigen 
even from non-cultivable microorganisms can be approached from 
reverse vaccinology
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ADVANCES IN POULTRY DIAGNOSTICS AND 
VACCINOLOGY
Real-time PCR based Diagnostics
In designing an effective disease control program one should 
consider the diagnostic methods used to diagnose diseases caused 
by infectious agents (Figure 4). In addition, the evolution of viruses 
and the emergence and reemergence of pathogenic and zoonotic 
viruses such as highly pathogenic AIV, zoonotic AIV strains, 
variant strains of IBV, very virulent strains of MDV and IBDV have 
placed considerable pressure on development of new diagnostics. 
Molecular diagnostic based on PCR based technologies especially 
real-time PCR has been proven as a valuable diagnostic for rapid 
and sensitive detections of evolving pathogens in the environments 
(reviewed by Suarez et al., 2007). 
 In general, real-time PCR can be divided into 2 types; first 
probe-based such as Taqman probes and molecular beacons both 
consist of an oligonucleotide specific to the gene of interest with 
a dye molecule on one end and quencher on the other (Espy et al., 
2006). Secondly, real-time PCR which is based on dyes that bind 
with dsDNA such as SYBR Green which has been considered the 
simplest method for real-time PCR but often difficult to optimize due 
to high dependency of the primers to target sequences. Fluorescence 
probe based real-time PCR have been developed and are used in 
diagnostic laboratory, i.e., for the detection and differentiation of 
NDV pathotypes (Aldous et al., 2001), IBDV subtypes (Jackwood 
et al., 2003a), IBV strains (Jackwood et al., 2003b), CAV strains 
(Markowski-Grimsrud et al., 2002) and AIV subtypes (Spackman 
et al., 2002).  Using similar technology, multiplex real-time PCR 
assays that are able to detect and differentiate viruses has also 
been developed. Recently, our group has also developed Taqman 
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real-time for the detection of different NDV genotypes as a tool to 
determine virus shedding from oral and cloacal of NDV vaccinated 
challenged chickens (Rasoli et al., 2014).
 The use of SYBR Green I based real-time PCR has also 
been explored for the detection and quantitation of poultry virus. 
Detection and differentiation of different strains of viruses via 
Sybr Green I based real-time PCR can only be achieved based on 
meting curve analysis (reviewed by Espy et al., 2006).  Hence, we 
have developed a triplex Sybr Green I based real-time PCR that 
able to detect and subtypes H9N2 virus based on detection of the 
NP, H9 and N2 genes (Ong et al., 2007). Subsequently, we have 
developed Sybr Green I based real-time PCR for the differentiation 
of lentogenic and virulent (mesogenic, velogenic) strains of NDV 
(Tan et al., 2009) and also very virulent IBDV from classical vaccine 
strain (Kong et al., 2009). 
New and Emerging Diagnostics
Currently, there is as yet no formal mechanism for the approval 
of diagnostic tests, although OIE has established guidelines of 
diagnostic tests, including commercial kits, through its worldwide 
network of over reference laboratories in different countries 
(http://www.oie.int/our-scientific-expertise/reference-laboratories/
introduction/). Under this guideline, four development requirements 
have been identified, validation, standard protocols, reference 
materials and proficiency test. In addition, the molecular diagnostics 
market is the fastest growing segment and is being driven by 
multiple growth factors such as the need for automated and easy-
to-handle techniques such as on-site test. One of recent advances 
in new diagnostic tools is the advent of microarray technology. 
A typical microarray consist of DNA probe (PCR products or 
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oligonucleotides) which can be efficiently printed on glass slide 
containing up to 100,000 spots, thus allowing for simultaneous gene 
expression analysis of many genes. These immobile DNA probes 
can then be hybridized with a labeled cDNA target samples in order 
to elucidate the genes expressed in that samples and determine 
at what relative level they are being expressed. Microarrays have 
been adopted for multiplexed detection of various targets such as 
pathogens as well as to profile the expression of thousands of genes 
simultaneously particularly immune-mediated genes following 
pathogens infections (Clewley et al., 2004; Gheyas and Burt, 2013). 
 Microarray has been used for typing and subtyping of various 
avian influenza virus strains depending on the different viral genes 
(Mukherjee and Chakrabarti, 2012). However, in most studies, the 
sensitivity of microarray was found to be 10- to 100-fold lower 
than that of real-time RT-PCR with respect to HA subtyping 
and pathotyping. Nevertheless, the specificity of the array was 
excellent, as no pathogens relevant for differential diagnosis yielded 
a positive reaction. Recently, the applications of microarray as a 
tool for diagnosis and  genome-wide transcriptional profiling of 
host responses to virus infection has been reviewed by various 
investigators (Mukherjee and Chakrabarti, 2012; Gheyas and Burt, 
2013).  Similar approach has been used to identify the differentially 
expressed mRNA in chicken cells infected with different pathogens 
such as IBDV, MDV and AIV. Hence, it is envisaged that future 
improvement in microarray technology may lead to the development 
of inexpensive and effective diagnostic for screening of animals. 
In addition, a simple and rapid on-site test for use in the field and 
laboratories to support clinical suspicion of disease is of importance 
in developing effective disease control strategy.
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Advances in Poultry Immunology
Chickens have several lymphoid tissues and organs such as 
bursa of Fabricius, Haderian gland and cecal tonsils that are 
unique compared to mammals. In addition, chickens lack distinct 
aggregate of lymphoid cells, commonly known as lymph nodes 
in mammals (Oláh and Vervelde, 2008). However, the chicken 
immune functions are very similar to mammals and share common 
features in the classification of innate and acquired immunity and 
the presence of different population of cells such as B cells, T 
cells, NK cells, macrophages and inflammatory cells. However, 
instead of neutrophils, chickens have heterophils that have similar 
inflammatory functions (Oláh and Vervelde, 2008). Advances in the 
characterization of chicken genome has identified numerous genes 
that are orthologs to human and mouse models such as Toll-like 
receptors that are involved in innate immunity and  various immune 
mediators namely interleukins, cytokines, chemokines, interferons 
and their receptors (reviewed by Kaiser, 2010).  The identification 
of IL-4 and related cytokines such as IL-10 and IL-13 which are 
involved in the Th2 response indicating that the chicken also induced 
Th1 and Th2 like responses following infection. Even cytokine 
genes which were previously thought to be mammalian-specific 
such as IL-3, IL-7, IL-9 and IL-26  were found in chickens.  
 The advancement in the genomic approach has also enhanced 
our understanding on the chicken MHC gene cluster which 
included the B-complex and Y-complex, previously known as 
Rfp-Y (Kaufman, 2008). Similar to the mammalian MHC genes, 
the chicken MHC Class I genes encode for surface receptors in all 
nucleated cells whilst MHC Class II genes encode receptors but are 
restricted to antigen presenting cells. However, in contrast to the 
mammalian MHC, chicken has a MHC genome segment that simpler 
27 ❘❘❚ 
Abdul Rahman Omar
but densely packed with genes (Kaufman, 2008). Characterization 
of the chicken MHC cluster has been of considerable interest due to 
the strong and reproducible of disease resistance with a particular 
MHC haplotype. Inbred chickens of different MHC haplotypes have 
been known to show different susceptibility to viral and bacterial 
infections ie. chickens of B21 and B19 haplotypes are resistance 
and susceptible to MDV infection, respectively (Kaiser, 2010). In 
the case of MDV, numerous studies have indicated that the genetic 
resistance towards MDV in chickens is associated with differences 
in NK cell and T cell functions and productions of various cytokines 
and nitric oxide (Omar et al., 1996; 1997; Omar and Schat, 1998; 
Schat et al., 2004)
 Studies are also underway in further characterization of chicken 
CD4+ T cells beyond Th1 and Th2 subsets since in mammals, CD4+ 
T cells can be classified into at least 4 different types based on 
surface markers and functions (Zhu et al., 2010). Recent studies have 
shown the presence of Treg cells in chickens (Shanmugasundaram 
and Selvaraj, 2010) however, the functions of this cell is not clearly 
understood. Further studies are required to identify whether the 
presence of other distinct CD4+ T cells such as Th2, Tr1, Th9 and 
Th17 cells do really exist in chickens.  
New Generation Vaccines and Adjuvants
Most of the advances in the development of the so called genetically 
engineered vaccines against poultry diseases using recombinant/
subunit protein, synthetic peptide, viral/bacterial vector and DNA 
vaccine technologies and reverse genetic approach are made in the 
past 20 years (Figure 5). However, the use of these vaccines in the 
poultry industry is very limited due to several reasons such as high 
cost to produce compared to the conventional vaccines, difficult 
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to administer the vaccine for mass vaccination, unclear regulatory 
issues, hence difficult or late for approval and difficult to integrate 
with the current conventional vaccines.   
 Table 2 shows some of the recombinant vaccines that have 
been licensed in the USA. Most of them used a poxvirus vector 
based vaccine ie. fowlpox virus vaccine vector containing the F 
and HN genes of NDV and MDV (Omar et al., 1998; Omar, 2012; 
2013; Jackwood et al., 2008). Other virus vector systems which 
have been developed are based on MDV serotype 3, herpesvirus of 
turkey (HVT) and adenoviral systems. Through the advancement 
in reverse genetic technology, researchers are exploring the use of 
RNA viruses such as AIV (Shi et al., 2007), NDV (Hu et al., 2009), 
IBV (Casais et al., 2001) and IBDV (Mundt et al., 2003) as viral 
vector vaccines. Using this technology, it is possible to construct 
avirulent or low virulent viral vaccines that express antigens of 
virulent field strains such as highly pathogenic H5N1 (Shi et al., 
2007) and velogenic genotype VII NDV (Hu et al., 2009). This 
has been shown in case of reverse genetic LaSota virus vaccine 
expressing the F and HN genes of genotype VII that able to  confer 
superior protection against mortality and virus shedding in SPF and 
commercial chickens following challenged with velogenic genotype 
VII NDV (Kiarash et al., submitted).
 The most extensively studied technology to produce 
recombinant/subunit proteins as vaccines is by using baculovirus 
expression system. This system have been used to express several 
avian viral proteins such as HN and F proteins of NDV (Ong et 
al., 1999a, b; Salih et al., 2000a), VP2 protein of IBDV, S1 protein 
of IBV,  various glycoproteins of MDV, viral proteins of CAV and 
HA and NA proteins of AIV (reviewed by Omar, 2005). Beside the 
baculovirus system, other systems that are available include yeast 
expression and prokaroytic  expression systems (Rabu et al., 2002; 
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Abubakar et al., 2011). Prokaryotic expression systems such as E. 
coli and other bacteria are not suitable especially for expression 
of proteins that require post-translational modification to become 
functional and immunogenicity in the immunized host (Sodoyer, 
2004). The yeast expression system is another attractive approach to 
express recombinant protein, however, the system require extensive 
optimization and only work for certain types of protein (Macauley-
Patrick et al., 2005). Studies have also shown that plant is also 
a suitable system for expression of heterologous proteins where 
several different proteins as diagnostics and/or vaccines have been 
tested experimentally (Sharma and Sharma, 2006; Teen et al., 2013). 
The application of recombinant protein based vaccine for poultry 
may not be feasible due to inherent challenge to produce the protein 
in mass amount in functional and stable manner for field testing. 
Nevertheless, the expressed proteins are suitable to be used for the 
development of diagnostic for rapid detection of avian pathogens 
based on various serology based assay. Recombinant proteins such 
as HN and F of NDV, HA, NA and NS1 of AIV, SI of IBV, VP2 
of IBDV are proteins with diagnostic potentials for the developed 
of diagnostic kits (Abubakar et al., 2011; Hosseini et al., 2007; 
Balamurugan et al., 2010). 
 Another important advancement in vaccine development is 
DNA vaccine (Figure 6). DNA vaccines against important poultry 
diseases namely NDV (Loke et al., 2005), IBV (Kapczynski et al., 
2003), IBDV (Chang et al., 2003), CAV (Moeini et al., 2011a, c) 
and H5N1 (Jazayeri et al., 2012a, b) have been recently studied 
by several groups. Although plasmid DNA-based vaccines have 
huge potentials over traditional vaccines, one of the major setbacks 
is that the vaccine is unable to induce strong immune responses 
(Redding and Weiner, 2009). Additionally, their applications in 
mass vaccination of livestock animals including poultry are poorly 
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studied. Despite extensive research, no licensed DNA vaccines are 
available commercially against poultry diseases.  Currently, only 
4 DNA vaccines have been approved for veterinary use, namely 
against West Nile virus in horses, infectious haematopoietic necrosis 
in salmon, the treatment of canine melanoma in dogs and for growth 
hormone releasing hormone (GHRH) products in swine (reviewed 
by Omar, 2012). 
Table 2  Currently licensed recombinant poultry vaccines 
(Source: Jackwood et al., 2008)
 
Company Pathogen Vector
Lohmann Animal 
Health
Salmonella 
typhimurium
Double-deletion-
mutant
Merial AIV, FPV FPV
Merial NDV, FPV FPV
Merial IBDV, MDV HVT
Intervet MDV HVT
Intervet MDV, NDV MDV
Bioimune Co. AEV, FPV, LTV FPV
Bioimune Co. NDV, FPV FPV
Bioimune Co. FPV, MG FPV
Bioimune Co. AEV, FPV, MG FPV
Bioimune Co. FPV, LTV FPV
AIV, avian influenza virus; NDV, Newcastle disease virus; IBDV, infectious bursal 
disease virus; MDV, Marek’s disease virus; AEV, avian encephalomyelitis virus; FPV, 
fowl poxvirus; LTV, laryngotracheitis virus; HVT, turkey herpesvirus; MG, Mycoplasma 
gallisepticum
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 Besides the advancement in development of vaccines, 
researchers are also characterizing new adjuvants and vaccine 
delivery systems to be used together with avian viruses (Rahman 
and Eo, 2012). Vaccine adjuvants can be defined as a component 
that enhances the immune responses to an antigen and/or modulates 
it towards the desired immune responses, hence, adjuvants are used 
primarily in inactivated vaccines. Most of the adjuvants that are 
used in poultry vaccines comprises of oil based adjuvants primarily 
water in mineral oil formulation. Beside oil based, aluminum 
based (aluminum hydroxide) adjuvants have also been tested for 
different poultry vaccines namely inactivated polyvalent vaccines. 
Development of new adjuvants able to broaden the induce immune 
response including cellular immune response as well as to extend 
the vaccinal cross- protection against different viral strains or 
serotypes. Some of the newer adjuvants that have been tested for 
poultry vaccine such as Montanide ISA 71 VG able to enhance the 
cellular responses (Liu et al., 2011). Since most of the adjuvants for 
poultry vaccine are oil based, they are able to induce side-effects 
such as inflammation, resulting in the down-grading of meat quality, 
alternative adjuvants must be developed. Some progress have been 
made in the development of new adjuvants which has been recently 
licensed such as monophosphoryl lipid A (MPL) and AS03 (a 
squalene-based adjuvant) (Rahman and Eo, 2012).
 The use of recombinant cytokines as adjuvants in poultry has 
been explored by several investigators (reviewed by Rahman and Eo, 
2012). Studies have shown that recombinant type I IFN (α and β) 
administered orally or through intravenous route inhibits replication 
of several avian viruses such as IBV, IBDV, NDV and AIV. 
Meanwhile type II IFN (g) play important role in chickens infected 
with Eimeria acervulina. Studies have also shown that the protective 
effects of g-IFN are further enhanced following the administration 
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of IL5 or IL-18 during intracellular bacterial infections. Although 
numerous studies have demonstrated the potential use of cytokines 
as vaccine adjuvant and therapeutic in poultry, their application in 
commercial chickens are problematic due to challenges such as 
high cost to produce in large scale production and retaining protein 
stability and bioactivity when administered in chickens. 
Table 3 Newer generations of diagnostic, vaccines and therapeutics 
against poultry pathogens 
No Research Innovation References   Patents
DNA Vaccine
1.
DNA vaccine expressing F and HN 
genes of NDV
Loke et al., 
2005
-
2.
DNA vaccine expressing H5 of 
AIV co-formulated with MDP-1 as 
genetic adjuvant
Jalilian et al., 
2010
-
3.
DNA vaccine expressing H5 of 
AIV co-formulated with HSP70 as 
genetic adjuvant
Rasoli et al., 
2010
-
4.
DNA vaccine expressing H5 of 
AIV co-formulated with ESAT-1 as 
genetic adjuvant
Oveissi et 
al., 2010
-
5.
DNA vaccine expressing VP1 and 
VP2 of CAV co-formulate with 
MDV VP22 as genetic adjuvant
Moeini et al., 
2011a, c
-
6.
Lactobacillus acidophilus as a 
live vehicle for oral immunization 
against chicken anemia virus.
Moeini et al., 
2011b
-
7.
Live attenuated salmonella as 
carrier for DNA vaccine expressing 
H5 of AIV
Jazayeri et 
al., 2012a, b
-
8.
Green synthesis silver nanoparticles 
nanoencapsulated H5 DNA vaccine
Jazayeri et 
al., 2012c, 
2013
-
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9.
DNA vaccine expressing H5 
formulated with chicken IL-15 and 
IL-18 as genetic adjuvant
Lim et al., 
2012
-
10.
DNA vaccine expressing N1 
formulated with chicken IL-15 as 
genetic adjuvant
Lim et al., 
2013
-
11.
DNA vaccine expressing NP 
formulated with chicken IL-15 as 
genetic adjuvant
Lim et al., 
2013
-
Molecular based Diagnostics
1.
Detection and distinguishing 
IBDV strains by molecular biology 
method
-
US7,858,768
EP1666608 B1
MY143506A
2.
Molecular differentiation of IBDV 
strains
Kong et al., 
2009
PCT/
MY2010/000002
3.
Assay for detection and 
quantification of NDV by real-time 
PCR
Tan et al., 
2009
PI20070884
4. Detection of avian influenza virus
Ong et al., 
2007
PI20062120
5.
The nucleocapsid protein of NDV 
as a carrier for immunogens
- PI20021709
6.
A novel antiviral peptide against 
AIV H9N2
Rajik et al., 
2009a, b
PI20082061
7.
A method for detection and 
differentiation of Mycoplasma 
gallispeticum
- PI2010000637
Others
1. Circular antiviral RNA
Oii et al., 
2014
PCT/
MY2013/000088
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 Due to the challenges working with recombinant cytokine as 
adjuvant for poultry vaccine, our group is exploring the use of 
immunomodulatory genes including cytokine as genetic adjuvant 
in enhancing efficacy of DNA vaccine against viral infection in 
chickens. Table 3 shows some of the different genes both cytokines 
and non-cytokine genes that have been used as genetic adjuvant 
in enhancing the efficacy of DNA vaccine against different 
pathogens in chickens. In one study, it was found that chicken IL-
15 and IL-18 are able to enhance the antibody and T cells function 
following the vaccination with H5, N1 and NP DNA vaccines in 
SPF chickens (Lim et al., 2012; 2013). Similar results were also 
demonstrated in the case of chickens immunized with H5 DNA 
vaccine co-administered with immunomodulatory genes such 
as Esat-1 (Oveissi et al., 2010), MDP-1 (Jalilian et al., 2010) or 
HSP70 (Rasoli et al., 2010) genes. Previous studies have shown 
that Esat-1 and MDP-1 genes of Mycobacterium tuberculosis and 
HSP70 exhibit strong adjuvant and immunomodulatory potential 
in mouse models (Wang and Singh, 2011).
 Even though the constructed H5 DNA vaccines when 
administered or co-expressed with the different genetic adjuvants 
are able to induce higher immune responses compared to 
vaccination with DNA vaccine alone, the vaccines still need to be 
administered parentally via intramuscular injection. To address 
this limitation, we have demonstrated that attenuated Salmonella 
typhimurium is a safe and effective vehicle for oral delivery of 
H5 DNA vaccine in chickens (Jazayeri et al., 2012a, b) (Figure 
7 and 8). In that study we showed that SPF chickens inoculated 
once with 109 Salmonella colony-forming units carrying H5 DNA 
vaccine developed HI titer > 50, elicited both CD4+ and CD8+ T 
cells with enhanced pro-inflammatory cytokine  (IL-1β, IL-12β, 
IL-15 and IL-18) expressions in spleen at 4 weeks post inoculation. 
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Figure 7 Colonization of chicken organs by attenuated Salmonella 
typhimurium carrying H5 DNA vaccine. The transfected bacteria were 
detected in cecum beyond day 35 post inoculation
Hence, single oral administrations of the attenuated S. typhimurium 
containing pcDNA3.1/H5 showed antibody, T cell and Th1-like 
cytokine responses against AIV in chickens.  Very recently, we 
managed to show that inactivation of S. typhimurium using novel 
approach are equally effective in delivering H5 DNA vaccine. 
Besides using bacteria we have also developed green synthesized 
silver nanoparticles as carrier for H5 DNA vaccine for rapid and 
effective expression (Jazayeri et al., 2012c; 2013). In addition, 
chickens immunized with H5 DNA vaccine encapsulated with 
the developed nanoparticle induced both antibody and T cells 
responses (Jazayeri et al., 2012c) (Figure 9, 10, 11, 12, and 13). 
Besides the development of vaccines, research is also in progress in 
the development of novel strategies in controlling pathogens using 
novel molecules such as antiviral peptide (Rajik et al., 2009a, b), 
RNA (Oi et al., 2014) and microRNA (unpublished results) which 
have huge potential as effective therapeutic agents. 
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Figure 8  Stability of DNA plasmids with HA, NA, NP of H5N1 in S. 
typhimurium. Fluorescence in situ hybridization detection of  (a) HA, 
(b) NA, (c) NP and (d) pcDNA3.1 as negative control after transfected 
into S. typhimurium. Probes were labeled with Cy5 (red), Alexa 
350 (blue) and Fluo (green) fluorescent dye. (e) In vitro stability of 
pcDNA3.1/HA, NA, NP and pcDNA3.1. S. typhimurium containing 
transfected plasmids were passaged for approximately 100 generations
e
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Figure 9 Characterization of the nanoencapsulated H5 DNA vaccine. 
TEM image and corresponding particle size and distribution of a) 
AgNP and b) AgNP/H5 show uniform shape, with maximum size of 
AgNP is 18 nm and AgNP/H5 is 25 nm
Figure 10  Viability and cytotoxicity assay of the nanoencapsulated 
H5 DNA vaccine. At the lowest concentration of AgNP (-5 log
10
) there 
were less than 10% dead cells.  Increasing the dosage of AgNP as high 
as -2 log
10
 the cells did not reach into EC50 ratio (45%)
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Figure 11  Antibody titer following oral immunization with 
nanoencapsulated H5 DNA vaccine. Each day-old chick received oral 
inoculation of 20 ng of pcDNA3.1/H5 nanoencapsulated with AgNP 
(3.7×10-2 ug of Ag). Chicken immunized with nanoencapsulated H5 
DNA vaccine developed significantly higher HI antibody responses 
(p< 0.05) compared to IM/H5 and nanoparticle inoculations 
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Figure 12  T cell responses following oral immunization with 
nanoencapsulated H5 DNA vaccine in chickens. Chicken immunized 
with nanoencapsulated H5 DNA vaccine developed significantly higher 
CD4+  and CD8+ T cell responses (p< 0.05) compared to IM/H5 and 
nanoparticle inoculations 
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Figure 13  Th1-like cytokine responses following oral immunization 
with nanoencapsulated H5 DNA vaccine. Increased in cytokine 
expression levels (5 to 20 fold) of splenic lymphocytes obtained 
from chickens immunized with nanoencapsulated H5 DNA vaccine 
in comparison with nanoencapsulated empty vector. The cytokine 
expressions were measured using GeXP system 
(Beckman Coulter, USA).
Prospects of Genetically Engineered Vaccines
The ultimate goal in developing genetically engineered vaccine is 
to develop an ideal vaccine through the advancement of innovative 
technology. Based on the guidelines by the Royal Society’s Report 
on Infectious Disease of Livestock in 2002, UK, the characteristics 
of an ideal vaccine is  
•	 provides broad spectrum protection against all isolates of the 
virus in all the affected species, preventing virus carriage and 
the possibility of shedding and transmission,
•	 stimulates the level of immunity necessary to drive an effective 
and long-lasting immune responses, 
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•	 inexpensive to manufacture and simple to administer, 
•	 safe to use, in the case of live vaccines, is safely attenuated and 
reversion to virulence is avoided, 
•	 long shelf life and is heat stable, 
•	 allows discrimination between infected and vaccinated animals, 
and  
•	 provides strong levels of maternal immunity.
 Nevertheless, there is no single vaccine that has all the above 
characteristics.  The use of vaccines to control disease is all about 
assessing the risk and evaluating the benefit following vaccination. 
Several promising leads have been made in the development of 
recombinant vaccines using viral and bacterial vectored vaccine 
technology and reverse genetic technology. In addition, through 
the use of genetically engineered vaccine, it will be possible to 
differentiate between animal that are vaccinated from infected, 
an important requirement that needs to be considered in disease 
eradication program. Furthermore, this requirement is also crucial in 
vaccination against animal diseases with public health implication.
 Vaccines have been proved to be effective against the widespread 
of diseases with the successful control and/or eradication of major 
animal diseases where vaccines are regularly used prophylactically 
to build flock immunity so that exposure with the disease agent 
does not result in an outbreak. Through the advancements of 
genetic engineered technology, vaccines may become increasingly 
important as an alternative therapeutics which will have a positive 
impact on the production and food safety by reducing or eliminating 
residues from the use of drugs and antibiotics. Furthermore, 
vaccines which induce rapid immunity are needed in the case of 
emergency vaccinations against endemic viral diseases. Hence, the 
development of multivalent vaccines would reduce the number of 
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inoculations to animals, reduce the handling cost and avoid animal 
sufferings.
 Effective delivery of genetically engineered vaccine via novel 
mass vaccination strategies including in ovo vaccination and 
compatible with the other current vaccines may further increase the 
acceptance of these new generation vaccines in poultry. However, 
the potential of new vaccines cannot be fully exploited if there is 
no public acceptance of the technologies used when safety and 
ethical concerns are involved. Efforts need to be made to educate 
the stakeholders as well as the public on the benefits and risks of 
new technologies.
“OMIC” TECHNOLOGY ON AVIAN DISEASES AND 
HEALTH
“Omic’ technologies can be defined as a comprehensive approach 
in the characterization of cell or organism based on high throughput 
profiling of genes (genomics), mRNA (transcriptomics), proteins 
(proteomics) and metabolites (metabolomics).  The advancement 
in “omic” technologies has enhanced research in the area of 
systems biology (systeomics), an emerging area in biomedical and 
biological research which uses holistic approach rather than the 
traditional reductionism approach to study the dynamic interactions 
between the biological components of the complex pathogen-host 
system (Aderem et al., 2011). Hence, rapid progress has been 
made in systems biology approach in elucidating host-pathogen 
interaction of several human diseases such as AIDS, influenza 
and tuberculosis. However, the use of system biology approach in 
avian disease is still at infancy. Nevertheless, some progress has 
been made in the characterization of the transcriptional regulatory 
networks between human, macaque and mouse model systems after 
infection with a highly pathogenic AIV H5N1 subtype (McDermott 
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et al., 2011). In that study it was found that the transcriptional 
regulations between in vitro and in vivo infection across different 
species are well conserved.
 In the past, expression study was done through RNA detection 
based on Northern blot analysis, a low throughput technique 
utilizing radioactivity and requiring large amounts of input RNA. 
The advancement in real-time PCR has significantly improved the 
quantitative expression study of know gene (Espy et al., 2006). The 
advances in high throughput sequencing technology have facilitated 
the full genome sequencing of various pathogens and other 
organisms including animals and plants. Sequencing of the chicken 
genome and pathogens of related importance has increased the 
development of other tools with diagnostic potential to investigate 
gene expression based on microarray technology. Currently, at 
least 3 different commercially available microarrays namely a 
20K Roslin/ARK CoRe Array,  a 33K Affymetrix GeneChip and 
a 44K Agilent microarray have been developed for whole genome 
transcriptome profiling in chicken (Gheyas and Burt, 2013). Hence, 
microarrays have made invaluable contributions in avian genomic 
research in various fields including embryology, immunology, 
oncology, virology and evolution. Chicken microarray is also a 
powerful tool to study immune response in avian species where 
little genome information is available. For instance, this has been 
shown in a study that characterized the pathogenicity of H5N1 in 
chickens is comparable to other avian species namely duck, goose 
and starling (Crowley et al., 2009).  
 One of the main challenges in microarray study is in analysis 
of the expression profiles which may lead to false results and 
interpretation (Freyhult et al., 2010). Furthermore, the development 
of microarray tools has been slow primarily due to cost for 
fabricating custom-made array. The future of microarrays is now 
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being questioned with the advent of massively parallel next-
generation sequencing (NGS) technologies, which promise to 
overcome some of the limitations of microarray platforms. NGS 
refers to a group of new sequencing technologies that can process 
millions of sequence reads in parallel, thus, able to generate 
enormous volume of sequencing data in a very cost effective 
way. Currently, at least 4 different platforms, 454 Life Sciences, 
Illuminia Solexa, Life Technologies and Pacific Biosciences are 
available commercially (Harun et al., 2013). NGS platforms have 
been  used in transcriptome profiling, miRNA profiling, DNA-
protein interaction studies using chromatin immunoprecipitation 
(ChIP) and DNA methylation studies, thus challenging the use of 
microarrays. 
 The advancement in NGS technologies has driven rapid progress 
on full genome projects of various microbes, plants and animals 
including different avian species. Furthermore, many bird species 
are important to agriculture and providing enormous worldwide 
food source, therefore the characterization of the genome of bird 
species has both social-economic and ecological importance. Hence, 
the genomes of several avian species such as chicken (Burt, 2005), 
duck (Huang et al., 2013) and turkey (Dalloul et al., 2010) have been 
sequenced. From these studies, genomic approaches are proving 
crucial information for studying traits that affect yield and disease 
resistance, behavior along with many factors affecting productivity. 
NGS has also been used to analyze  host-pathogen interactions in 
poultry following infections with various avian pathogens such 
as MDV and AIV (Cheng et al., 2012, The SJCEIRS H9 Working 
Group 2013), the expression of chicken microRNA (Buermans 
et al., 2010) and the structural variation within different chicken 
lines (Kerstens et al., 2011). Studies have shown that certain inbred 
chicken lines can be classified as resistant and susceptible breeds 
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towards infection with MDV, IBDV and Salmonella (Kaiser, 2010). 
Recently, we have explored the use of strand-specific sequencing 
of Illuminia Hiseq technology to characterize the transcriptome of 
bursal tissue following infection with very virulent strain of IBDV 
(Noor Farhanah et al., 2012). Works are currently underway in 
elucidating the differential expression of various set of immune-
mediated genes between the different lines of these inbred chickens. 
Using NGS based technology, our group has also started to sequence 
and characterize several different animal pathogens of interest in the 
effort to develop new strategies to control the diseases, this include 
complete genome sequencing of several NDV strains (Murulitharan 
et al., 2013, unpublished results), bacteriophage (Gan et al., 2013) 
and Pasteurella multocida (Yap et al., 2013). Various studies at 
transcriptional level (Figure 14, Rasoli et al., 2014) and complete 
genome sequencing of genotype VII NDV (unpublished results) are 
currently underway to address the reason why the current genotype 
VII NDV is difficult to be controlled using conventional LaSota 
vaccine.  
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Figure 14  Modulation in the expressions of chemokines, cytokines and 
other immune-related genes in spleen of NDV genotype VIII AF2240 
and genotype VII IBS002 infected chickens. Both NDV genotypes 
induced strong proinflammatory and Th1 cytokines but show different 
expression patterns
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ECONOMIC AND SOCIAL IMPACT OF ANIMAL 
DIAGNOSTICS AND VACCINES
Global Animal Vaccine Market
The global animal vaccine market which was valued at USD$5.4 
billion in 2012 is expected to reach US$8 billion by 2018. This is 
primarily driven by the accelerated growth of the livestock sector 
than any other agricultural sub-sector, the growing prevalence 
of animal diseases, increasing incidences of zoonotic diseases 
in humans, increasing investments by government bodies and 
animal welfare associations, as well as continuous innovations and 
introductions of new products. The large share of this segment is 
attributed to their major use of animals related to the food industry 
(meat, chicken, eggs, and dairy products) where according to Food 
& Agriculture Organization, global meat production is projected 
to more than double from 229 million tonnes in 1999/2001 to 465 
million tonnes in the year 2050.  
 Among the biggest challenges in livestock industry are 
management and control of infectious diseases through the use of 
various biosecurity approaches including the use of diagnostics, 
vaccines and other therapeutics. The burden of infectious diseases 
in livestock and other animals continues to be a major constraint to 
sustain agricultural development, food security and the participation 
of developing and in-transition countries in the economic benefits 
of international trade in livestock commodities.
 The world market for animal vaccines is largely for cattle, pet/
small animals and poultry industry (Figure 15). These products 
are mainly produced by large pharmaceutical companies, such as 
Pfizer/Zoetis (USA), Merck (USA), Sanofi-Aventis (France), Bayer 
HealthCare (Germany), Virbac (France), Novartis (Switzerland), 
Boehringer Ingelheim (Germany), Heska Corporation (USA), 
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Bioniche Animal Health (Canada), and Ceva (France), which are 
the key players in the global animal vaccines market. These large 
multinational companies have R&D and manufacturing facilities 
in different parts of the world.   
National Scenario 
Besides research on conventional animal diagnostics and vaccines 
for the immediate and changing needs at national and global 
levels, most of the current researches at UPM are in line with the 
advancements in technology and science of infectious diseases 
and immunology for the development of new generation vaccines 
and improving the quality of existing diagnostics and vaccines. 
Furthermore, researchers are actively engaging in the area of vaccine 
delivery systems using novel carriers as well as adjuvants in an 
effort to enhance vaccine induced responses and to develop vaccine 
which are able to induce the required immune responses against 
an infectious agent. As described previously, the animal vaccines 
market comprised of live attenuated vaccines, inactivated vaccines, 
subunit vaccines, recombinant vaccines and DNA vaccines.  It is 
envisioned the DNA vaccines technology will be the fastest-growing 
technology due to its cost effectiveness and easy production, rapid 
development against emerging diseases, and added thermo-stability 
between 4°C to 20°C in comparison with traditional vaccines (http://
www.marketsandmarkets.com/Market-Reports/animal-veterinary-
vaccines-market-1233.html). Hence, our group has developed 
several DNA vaccines against poultry disease with novel mass 
applications that do not require multiple injections of individual 
animals (Table 3).  
 Research and innovation in the areas of animal diseases and 
health towards the development of diagnostics and vaccines/
therapeutics have been the main research focus of UPM due to 
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the unique combinations of experts from different fields such as 
veterinary, marine science, biomedical, biotechnology, agriculture 
and engineering. Hence, over the past 15 years, numerous 
achievements in the form of high impact publications, prestigious 
awards, industry-relevant innovations and research outputs, and 
commercialised products have propelled UPM to be at the forefront 
of research and discovery. The achievements are as follows;
•	 More than 15 experts (Professors and Associate Professor) in 
the field of poultry disease, vaccine and related research.
•	 More than 200 post-graduate students specializing in poultry 
diseases, vaccine and related research have graduated. 
•	 Patents in poultry vaccine and health related innovations/
products
 » 3 international patents (2 USA and 1 EU) on avian viruses 
and vaccine application
 » 10 patent pending on avian pathogens and vaccine/diagnostic 
applications
•	 Three poultry vaccines, NDV, FPV and IBDV have been 
commercialized. It is anticipated at least 3 more poultry 
vaccines are to be commercialized in the next 2 to 3 years.
•	 ISO17025 accredited laboratory tests for the detection of 
animal pathogens
•	 WHO/CDC compile BSL-3 laboratory  
 The government, through relevant Ministries, has identified 
UPM as the torch bearers of excellence in agricultural based 
research and innovation. Researchers from various faculties 
especially Faculty of Veterinary Medicine, Faculty of Agriculture 
and Faculty of Biotechnology and Biomolecular Science are actively 
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engaging research in animal vaccines and related technology. 
Furthermore, Institute of Bioscience has been  recognized as one 
of the six Higher Institution Centres of Excellence (HICoE) in the 
country by Ministry of Higher Education in 2010 to spearhead 
excellence in animal vaccine and therapeutic research to the next 
level of international repute meeting the changing needs of the 
nation and the world.  Currently, Malaysia imports vaccines and 
pharmaceuticals worth RM650 million annually. Department of 
Veterinary Service (DVS) is looking into ways of producing at 
least 30% of total import of vaccines as alternative to imported 
ones (New Straits Times / BERNAMA -01/03/2010). Currently, 
31 vaccines have been produced locally by DVS and Malaysian 
Vaccine Pharmaceuticals (MVP) (Table 4). 
 The looming of highly pathogenic AIV H5N1 in this region 
and the emergence of new AIV strains such as H7N9 and H10N8 
also requires our researchers to develop new strategy including 
diagnostics and vaccines against the respective viruses. The 
development of effective AIV diagnostics and vaccines are essential 
since during the outbreak of H5N1 in 2004, Malaysia lost more than 
RM1 million each day due to the inability to export poultry meat 
and byproducts to other countries. Further losses were incurred 
due to depopulation of infected and suspected infected birds. 
The investment in R&D in the development of improved or new 
animal diagnostics, vaccines and pharmaceuticals is expensive 
and currently being carried out primarily in public universities/
RI. Besides grant for research and innovation, emphasis must also 
be given to build suitable containment facilities for both basic 
research and clinical trials. Currently, no single organization has an 
overview to ensure an integrated and coordinated R&D program in 
Malaysia. Availability of this information would lead to effective use 
of resources, reduce duplication of effort, encourage collaboration 
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and identify key gaps in research. One of the ways to move forward 
is to establish more industry driven research via high degree of 
industry and academia collaboration as it will improve access to 
expertise and results in shorter lead time to market the products.
Figure 15  Global veterinary vaccines demand in 2010 
(Source: Dolcera Analysis)
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AVIAN VIRUSES AS HUMAN VACCINES AND 
THERAPEUTICS
Oncolytic Virotherapy 
It has been well established that several animal viruses preferentially 
infect and kill human cancer cells, hence they are collectively known 
as oncolytic virotherapy (OV) (Kelly and Russell, 2007). Currently, 
there are extensive evidences indicating that OV is effective in 
treating cancer in both preclinical animal study and human patient 
clinical trials. Among OVs which have been used are adenovirus, 
herpes simplex virus, reovirus, measles virus and NDV (Lam et 
al., 2011). These viruses preferably kill cancer cells while leaving 
normal cells unharmed. Therefore, patients who have gone through 
clinical trials using oncolytic viruses have reported minimal or no 
side effects, and have shown an increased survival rate and enhanced 
tumour regression. 
Poultry Viruses as Cancer Therapy 
Several different poultry viruses such as NDV, IBDV and CAV 
have been showed to selectively destroy human cancer cells. Unlike 
other avian viruses, studies from as early as in the 1940s have 
shown the potential of NDV as an anti-cancer agent. NDV mediated 
cancer therapy can be divided into two distinct types based on the 
characteristics of the virus. The non-lytic NDV strains, e.g. Ulster, 
infect tumour cells and produce non-infectious viral particles which 
lead to an abortive viral replication, whilst the infection of tumour 
cells by the lytic NDV strains, e.g. MTH-68, lead to a multi-cyclic 
replication as infectious viral particles are produced that can infect 
other tumour cells, thereby amplifying the viral load (Zamarin 
and Palese, 2012). It is envisaged that NDV as an effective cancer 
therapy since it is able to remove tumor effectively by inducing 
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selective cancer apoptosis as well as activation of effective cancer 
immune responses for complete removal of cancer cells (Figure 
16, Nakajima et al., 2013). 
 Several Malaysian NDV strains have been screened for their 
oncolytic effect on different cancer cell lines such as as CEM-SS 
(T-lymphoblastic leukemic cells), MCF-7 and MDA-231 (breast 
cancer), HT29 (colorectal cancer) and HL60 (acute promelocytic 
leukemia) (Abdul Rahman et al., 2003). However, most of the 
study focuses on NDV strain AF2240, a velogenic NDV isolated 
in 1960s. In vitro studies have indicated that the AF2240 is a lytic 
NDV that selectively induces apoptosis of MCF-7, an estrogen 
receptor positive human breast cancer cells (Ghrici et al., 2013a, 
b; Jamal et al., 2012).
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 In addition, NDV AF2240 also induces apoptosis of other cancer 
cells, such as the WEHI-3B leukaemia cells (Alabsi et al., 2011; 
2012), anaplastic astrocytoma U-87MG (Ali et al., 2011) and the 
cervical cancer cells, HeLa (Molouki et al., 2011).
 The mechanisms of NDV-induced oncolysis are not well 
understood, although phase II/III clinical trials on humans are 
currently underway (Zamarin and Palese, 2012). Understanding the 
mechanisms of NDV induced oncolysis will facilitate the use of 
NDV as oncogenic reagents together with other therapies in human. 
Studies have shown that the involvement of both the activation of 
intrinsic and extrinsic caspase-dependent apoptosis pathways as 
well as the type 1 IFN dependent and independent mechanisms in 
NDV mediated oncolysis (Mansour  et al., 2011). Recently, we have 
found that AF2240 induced oncolysis of MCF-7 cells associated 
with activation of caspase-8 and mitochondrial transition pore 
opening that is independent of both virus replication and protein 
synthesis (Ghrici et al., 2013a). In addition, the expression of the 
HN gene alone was able to induce apoptosis in MCF-7 cells but it 
was a less potent apoptosis inducer compared to the parental NDV 
AF2240 strain (Ghrici et al., 2013b).  Hence, mitochondrial-related 
pathway may be the central activator in NDV strain AF2240-induced 
apoptosis. AF2240 also caused significant cell death towards MCF-
7 cells compared to normal breast cancer cells, MCF-10A cells, 
therefore analyzing the differential expression of genes in both cell 
lines may  provide valuable information on mechanisms of NDV 
induced oncolysis. Recently, we have performed  in silico analysis 
to predict and analyse the protein-protein interactions and identify 
potential pathways involved in the interactions between NDV strain 
AF2240 and MCF-7 breast cancer cell line. In that study, we found 
a total of 26 NDV-interacted proteins which were recognized as 
potential candidates might be responsible for inducing the selective 
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destruction of the MCF-7 breast cancer cell line (Khairiyah et 
al., submitted).  Studies are currently underway in validating the 
functions of these genes in modulating ability of NDV induced 
oncolysis of MCF-7 cells.  
 Besides NDV, limited studies have also showed the potential of 
other avian viruses such as AIV and IBDV in selectively destroying 
human cancer cells (Voon et al., 2005). One of the recent advances 
in the use of avian viruses as cancer therapy in humans is the 
application of VP3 protein (apoptin) of CAV in the destructions of 
human cancer cells (Shen et al., 2013). Studies have shown that 
the expression of VP3 of CAV in cancer cells associated with the 
induction of apoptosis through caspase-3 and caspase-9 dependent 
intrinsic mitochondrial pathways. Interestingly, the majority of 
cancer cells which are susceptible to VP3 induced apoptosis are 
Bcl-2 dependent but are independent of p53 related pathway. Hence, 
apoptin is an attractive gene therapy for human cancer since many 
anticancer therapies require wild-type p53 expressions for effective 
destruction (Backendorf  et al., 2008).
Recombinant Avian Viruses as Vectored Vaccines 
Emerging and re-emerging infectious diseases pose significant 
threats to global human health and require the development of 
new diagnostics, therapeutics and vaccines. Various vaccine 
technologies, in particular, recombinant virus as vaccine vector have 
shown great promise and play an important role in the development 
of new generation vaccines. An ideal vaccine is a vaccine that is 
able to mimic natural infection without showing the overt infection. 
 With the advent of reverse genetic technology, several different 
animal viruses have been used as recombinant viral vector vaccines 
for humans. In the case of poultry viruses, NDV has been showed 
to have valuable potential as human viral vector vaccine. Why is 
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NDV an attractive recombinant viral vector vaccine for human? 
Newcastle disease virus is a unique avian virus that is highly 
attenuated in humans and other primates because of a strong host-
range restriction. NDV infects the respiratory tract of non-human 
mammals and appears to remain restricted to that site (Bukreyev 
and Collins,  2008). In addition, NDV is antigenically distinct from 
common human viruses, able to express stable foreign proteins 
and easily propagated in different cell lines for human product 
development. Studies have shown the potential applicability of 
live attenuated lentogenic NDV as recombinant vaccine against 
influenza,  severe acute respiratory syndrome, highly pathogenic 
H5N1, human immunodeficiency virus, rabies, measles, Nipah 
disease, Rift Valley fever and Ebola (Wen et al., 2013). Hence, these 
studies indicated that NDV is a safe and effective viral vectored 
vaccine in various animal models such as mice, dogs, pigs, cattle 
and sheep including humans. 
CONCLUSION
Diagnostic tests and vaccines are valuable tools in the diagnosis 
and control of poultry diseases.  Most of the vaccines currently in 
use for the control of animal diseases are conventional vaccines 
whilst, serological based tests are routinely used to determine the 
effectiveness of control program and as an aid in the diagnosis of 
diseases. The use of molecular diagnostics especially PCR based 
tests are making its way as important rapid and accurate tools in the 
detection of avian pathogens. However, new and emerging infections 
will continue to pose risks to the human and animal population. 
Continuous research and development are required to develop new 
innovations for poultry diagnostics, vaccines and pharmaceuticals. 
Innovative technologies offer new opportunities through real-time 
PCR, microarray, adjuvant and reverse genetic technologies and 
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sequencing which have allowed the identification of the genes in 
viruses that are responsible for disease and stimulating immune 
responses. This will enable the development of safe and effective 
live recombinant vaccine strains that mimic natural infection 
without showing any overt infection. Improved diagnostic tests 
must be developed to enable the early diagnosis and detection of 
outbreaks along with tests to determine the effectiveness of disease 
control program. In addition, a proactive approach for the detection 
of new virus which seems to be lacking needs to be established 
through research collaborations with universities/research institutes 
and the relevant industries. This is crucial in order to respond 
rapidly to new and emerging threat especially zoonotic diseases. 
Strengthening innovative research via multi-disciplinary approach 
is required to leverage the full potential of avian viruses as therapy 
for deadly human diseases.  Although Malaysia and many countries 
in this region have relatively strong scientific research but the 
translation of scientific discoveries into innovative products with 
high commercial values is a complex process involving various 
factors including economic, regulatory and social issues.
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